色谱 ›› 2025, Vol. 43 ›› Issue (10): 1119-1126.DOI: 10.3724/SP.J.1123.2025.03025

• 研究论文 • 上一篇    下一篇

超高效合相色谱-串联质谱法快速检测药用复合膜中12种光引发剂残留

曹运姣1, 刘晨曦2, 陈雷霖2, 尚悦3, 陈晓莉2, 胡贝2, 付蒙2,*(), 胡敏1,2,*()   

  1. 1.湖北中医药大学药学院,湖北 武汉 430065
    2.湖北省药品监督检验研究院,湖北省药品质量检测与控制;工程技术研究中心,国家药品监督管理局中药质量控制重点实验室,湖北 武汉 430075
    3.国家药典委员会,北京 100061
  • 收稿日期:2025-03-27 出版日期:2025-10-08 发布日期:2025-09-24
  • 通讯作者: *Tel:(027)87705232,E-mail:humin@hubyjs.org.cn(胡敏); Tel:(027)87705260,E-mail:fumeng@hubyjs.org.cn(付蒙).
  • 基金资助:
    湖北省药品监督检验研究院中青年科研基金资助项目(2022YN004)

Rapid determination of 12 photoinitiator residues in medicinal composite membranes by ultra performance convergence chromatography-tandem mass spectrometry

CAO Yunjiao1, LIU Chenxi2, CHEN Leilin2, SHANG Yue3, CHEN Xiaoli2, HU Bei2, FU Meng2,*(), HU Min1,2,*()   

  1. 1. School of Pharmacy,Hubei University of Chinese Medicine,Wuhan 430065,China
    2. Hubei Institute for Drug Control,Hubei Engineering Research Center for Drug Quality Control,National Medical Products Administration;Key Laboratory of Traditional Chinese Medicine,Wuhan 430075,China
    3. Chinese Pharmacopoeia Commission,Beijing 100061,China
  • Received:2025-03-27 Online:2025-10-08 Published:2025-09-24
  • Supported by:
    Scientific Research Project for Young and Middle-aged Researchers of Hubei Institute for Drug Control(2022YN004)

摘要:

建立了超高效合相色谱-串联质谱(UPC2-MS/MS)快速测定药用复合膜中12种光引发剂残留量的方法。以乙腈提取药用复合膜中残留的光引发剂。采用ACQUITY UPC2 CSHTM Fluoro-Phenyl色谱柱(100 mm×3.0 mm, 1.7 μm)进行分离,以超临界二氧化碳-甲醇为流动相进行梯度洗脱,以甲醇-水(99∶1,v/v)为补偿液。流动相流速为1.5 mL/min,补偿液流速为0.2 mL/min,系统背压为13.79 MPa,柱温为50 ℃,进样量为1 μL。采用电喷雾(ESI)离子源,在正离子多反应监测(MRM)模式下检测12种光引发剂的离子对,外标法定量。结果表明,12种光引发剂在0.1~2.0 μg/mL范围内具有良好的线性关系,相关系数(r)> 0.995,检出限(LOD)均为0.03 μg/mL,定量限(LOQ)均为0.1 μg/mL。12种光引发剂在3个加标水平下的加标回收率为80.7%~119.7%,相对标准偏差为1.0%~5.6%。采用该方法对12批药用复合膜进行测定,共发现6批阳性样品,检出的4种光引发剂分别为4-甲基二苯甲酮、邻苯甲酰苯甲酸甲酯、二苯甲酮和2-异丙基硫杂蒽酮,其中邻苯甲酰苯甲酸甲酯的检出量最高,未超过拟定限度。本方法准确、灵敏、快速、环保,样品前处理简便,适用于监测药用复合膜中光引发剂的残留量,能为药品包装材料质量标准的完善提供研究基础。

关键词: 超高效合相色谱-串联质谱, 超临界CO2, 药用复合膜, 光引发剂

Abstract:

Photoinitiators are indispensable components in the formulation of inks used for printing packaging materials. Residual photoinitiators on the surface of packaging materials may migrate and contaminate the contents, posing potential risks to human health. Toxicological experiments have shown that photoinitiators pose various risks, including carcinogenicity, reproductive toxicity, and dermal toxicity. However, current quality standards for pharmaceutical packaging materials, both domestically and internationally, do not impose limits on photoinitiators. This study focuses on 12 photoinitiators, which are either restricted or prohibited in certain fields such as food packaging materials. The selected medicinal composite membranes, widely employed in pharmaceutical packaging and requiring significant ink volumes, serve as representative samples. This research holds significant implications for improving the quality standards of pharmaceutical packaging materials and ensuring medication safety. While gas chromatography-mass spectrometry and ultra performance liquid chromatography-tandem mass spectrometry have been reported for photoinitiators detection, UPC2-MS/MS has not yet been reported for detecting these compounds. The principle of UPC2 is based on supercritical fluid chromatography, where the mobile phase primarily consists of supercritical CO2 with a minimal use of organic solvents, aligning with the trend of green chemistry. When coupled with MS, this method also enhances the sensitivity of detection. Therefore, a novel method based on UPC2-MS/MS was established for the determination of the 12 photoinitiator residues in medicinal composite membranes. MS conditions, makeup solution conditions (solvent, additive type, additive ratio, flow rate), and sample pretreatments were systematically optimized. Photoinitiator residues were extracted from the medicinal composite membranes using acetonitrile by ultrasonication. The chromatographic separation was achieved on a UPC2 CSHTM Fluoro-Phenyl column (100 mm × 3.0 mm, 1.7 μm) under gradient elution using a mobile phase composed of supercritical carbon dioxide (A) and methanol (B). Gradient elution was performed as follows: 0-1.5 min, 100%A-95%A; 1.5-2.0 min, 95%A-80%A; 2.0-3.0 min, 80%A-70%A; 3.0-4.0 min, 70%A-100%A; 4.0-5.0 min, 100%A. A methanol-water (99∶1, v/v) mixture was employed as the makeup solution to enhance MS response. The mobile phase flow rate, makeup solution flow rate, column temperature, and injection volume were respectively set at 1.5 mL/min, 0.2 mL/min, 50 ℃ and 1 μL. The automatic back pressure regulator maintained 13.79 MPa. The 12 photoinitiators were monitored in multiple reaction monitoring (MRM) mode with electrospray ionization (ESI) under positive conditions. Quantification was performed using the external standard method. The results showed that all 12 photoinitiators exhibited good linear relationships in the range of 0.1-2.0 μg/mL, with correlation coefficients (r)>0.995. The limits of detection (LODs) and quantification (LOQs) for the 12 photoinitiators were 0.03 μg/mL and 0.1 μg/mL, respectively. At 1LOQ, 2LOQ, and 10LOQ levels, the average recoveries of the 12 photoinitiators ranged from 80.7% to 119.7%, with relative standard deviations (RSDs) between 1.0% and 5.6%. Twelve batches of medicinal composite membranes were tested using this method, and six batches were found positive. The detected photoinitiators were 4-methylbenzophenone, methyl-2-benzoylbenzoate, benzophenone, and 2-isopropylthioxanthone. Among them, methyl-2-benzoylbenzoate showed the highest concentration, but it did not exceed the proposed limit. The established method is accurate, sensitive, rapid, environmentally friendly, and simple pretreatment, which is suitable for monitoring residual photoinitiators in medicinal composite membranes.

Key words: ultra performance convergence chromatography-tandem mass spectrometry (UPC2-MS/MS), supercritical CO2, medicinal composite membranes, photoinitiators

中图分类号: